TNFRSF1A and neoplasm: However TNF-alpha mutants have been developed that specifically bind either TNF-R1 or TNF-R2 [49] and novel mutants have been obtained with lower toxicity and increased anti-tumor activity compared to wild type TNF-alpha [50].